emmarayner, Author at European Medical Journal - Page 5 of 18

Gene Therapy in Haemophilia: Updates from Clinical Trials and Insights to Future Technologies

At the International Society on Thrombosis and Haemostasis (ISTH) 2022 Congress, held 9th–13th July, multiple oral and poster presentations were dedicated to gene therapy as a treatment for haemophilia A or B.

The Role of Radiologists in Screening Programmes for Lung and Prostate Cancer

DETECTING cancer at an early stage is a multi-faceted challenge for clinicians. Screening programmes aid identification of disease before symptoms arise, when prognosis is likely to be better. However, several barriers affect implementation, uptake, and delivery of these programmes.

Innovative Upper Gastrointestinal Stenting

Self-expanding metal stents (SEMS) have been established beyond doubt as an effective tool in the palliative management of malignant gastrointestinal tract strictures.

Progesterone Resistance in Endometriosis

Endometriosis is characterised by the presence of endometrium-like tissue on the pelvis and other organs. Progesterone resistance due to suppressed progesterone receptor (PGR) expression and action is a general feature of endometriosis and is a cause of endometriosis-associated chronic pelvic pain, infertility, inflammatory disorders, and cancer.

EMJ Urology 10.1

Review of the 37th Annual Meeting of the European Association of Urology (EAU) 2022

THE 37th Annual Meeting of the European Association of Urology (EAU) took place in Amsterdam, the Netherlands, and online between the 1st–4th July 2022. The opening ceremony began with a piano performance from the talented Wibi Soerjadi and a unique artistic display from a sand magician, who demonstrated his art by using sand alone.

EMJ Urology 10.1

Let’s Take a Look at the Very Best of EAU22: Great Topics, Great Research, and Great Teamwork

The European Association of Urology (EAU) delved into the very latest in urological science at the 37th Annual Congress, EAU22, on 1st–4th July in Amsterdam, the Netherlands. The four days were filled to the brim with 2,580 presentations by more than 900 speakers, and 56 courses organised by the European School of Urology (ESU).

Allergy 71 Feature Image

Reconsider the Art of Allergen Immunotherapy

This symposium took place during the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress, held in Prague, Czechia, in July 2022.

Allergy 71 Feature Image

Changing the Way Babies Eat: Supporting Early Allergen Feeding Around the World

This symposium occurred during the European Academy of Allergy and Clinical Immunology (EAACI) Congress, 2022.

Huntingtin as a Presymptomatic Regulator of Alzheimer’s Disease

The identification of pathological elements that drive disease progression, so-called regulators, is essential when studying progressive diseases.

EMJ

MRI Response Assessment in Patients with Glioblastoma Treated with Dendritic Cell-Based Immunotherapy

In glioblastoma (GB), patients’ reliable response assessment criteria are crucial in order to accurately compare the responsiveness of different therapies in clinical trials, and to differentiate between therapy-induced changes and true tumour progression.